• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Graviti`s Generic Hydroxyzine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of December 30, 2020

    FDA

    Erfa Canada recalls ATARAX (hydroxyzine) due to resulting in a potential risk

    HEALTH CANADA

    Dr Reddy`s Lab completes acquisition of UCB`s select brands

    BUSINESS TODAY

    Akorn, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Failed Impurities/Degradation Specifications

    FDA

    Advanced Physician Solutions, Inc. initiates Class II recall of Hydroxyzine Hydrochloride due to Lack of Assurance of Sterility

    FDA

    New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines

    EMA

    PRAC recommends new measures to minimise known heart risks of hydroxyzine-containing medicines

    EMA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.